“The 16th Annual Discovery on Target” takes place in Boston on September 25 – 28.
The meeting is one of the industry’s main events for discussions about new target proteins for drug development. The fact that an entire day is devoted to autophagy shows what we previously communicated; a strongly increased interest in autophagia as a goal for the development of new innovative drugs. Sprint Biosciences Head of Research, Martin Andersson, will monitor the field on behalf of the company.
Link to the meeting here
